Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.65 |
| ▸ | HTR2C | P28335 | 1/20 | 0.65 |
| ▸ | HTR2B | P41595 | 1/20 | 0.65 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.54 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.54 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3813110 | 1.00 | HTR2A (0.65) | HTR2AHTR2CHTR2BTAAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL10555614 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BTAAR1SLC6A2 | |
| SCHEMBL22341176 | 0.83 | EPHX2 (0.63) | HTR2AHTR2CHTR2B | |
| SCHEMBL2662219 | 0.83 | ALDH1A1 (0.55) | HTR2AHTR2CHTR2BTAAR1SLC6A2 | |
| SCHEMBL10872755 | 0.82 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL10872752 | 0.82 | TAAR1 (0.76) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL9292319 | 0.81 | SLC6A4 (0.58) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL14478293 | 0.81 | SLC6A4 (0.58) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL4875435 | 0.81 | SLC6A4 (0.58) | TAAR1SLC6A2SLC6A3SLC6A4MAOA | |
| SCHEMBL681378 | 0.81 | GRB2 (0.53) | HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183618-A1 | PSYCHEDELIC COMPOSITIONS AND METHODS FOR FORMING THE SAME | OJAI ENERGETICS PBC (US) | 2023-09-28 | — | — | WO | claimed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | claimed |
| WO-2014001075-A1 | PROCESS FOR RACEMIZING OPTICALLY ACTIVE ARYLALKYLAMINES | BASF SE (DE) | 2014-01-03 | — | — | WO | claimed |
| US-20130345475-A1 | PROCESS FOR THE RACEMIZATION OF OPTICALLY ACTIVE ARYLALKYLAMINES | BASF SE (DE) | 2013-12-26 | — | — | US | claimed |
| EP-4499109-A1 | PSYCHEDELIC COMPOSITIONS AND METHODS FOR FORMING THE SAME | Ojai Energetics PBC (US) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023183618-A1 | PSYCHEDELIC COMPOSITIONS AND METHODS FOR FORMING THE SAME | OJAI ENERGETICS PBC (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-116768737-A | Preparation method of interface passivation material and perovskite passivation layer | 武汉理工大学 | 2023-09-19 | — | — | CN | disclosed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | disclosed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | disclosed |
| US-20220102660-A1 | DEFECT SUPPRESSED METAL HALIDE PEROVSKITE LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING DIODE COMPRISING THE SAME | SN DISPLAY CO., LTD. (KR) | 2022-03-31 | — | — | US | disclosed |
| WO-2021125412-A1 | DEFECT-SUPPRESSED METAL HALIDE PEROVSKITE LUMINESCENT MATERIAL, AND LIGHT-EMITTING DIODE COMPRISING SAME | 서울대학교산학협력단 | 2021-06-24 | — | — | WO | disclosed |
| WO-2021125412-A1 | DEFECT-SUPPRESSED METAL HALIDE PEROVSKITE LUMINESCENT MATERIAL, AND LIGHT-EMITTING DIODE COMPRISING SAME | 서울대학교산학협력단 | 2021-06-24 | — | — | WO | disclosed |
| US-6153797-A | CATALYTIC RACEMIZATION OF AMINES WITH HYDROGENATION AND DEHYDROGENATION WITH CATALYSTS AND HEATING WITH ALUMINA, ZIRCONIA, TITANIA AND SILICA | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-28 | — | — | US | disclosed |
| EP-1045025-A1 | (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE | KANEKA CORPORATION (JP) | 2000-10-18 | — | — | EP | disclosed |
| WO-2000029357-A1 | METHOD FOR RACEMIZATION OF OPTICALLY ACTIVE AMINES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-25 | — | — | WO | disclosed |
| US-6049007-A | REACTING IN SITU AN OPTICALLY ACTIVE AMINE, SECONDARY ALCOHOL OR UNSYMMETRICAL KETONE AND A PRIMARY AMINE IN PRESENCE OF HYDROGEN AND HYDROGENATION OR DEHYDROGENATION CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-11 | — | — | US | disclosed |
| US-4857553-A | SIDE EFFECT REDUCTION | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-08-15 | — | — | US | disclosed |
| CN-1033797-A | The N-phenylalkylbenzamidefungicides fungicides | LILLY CO ELI (US) | 1989-07-12 | — | — | CN | disclosed |
| EP-0302757-A2 | Anti-emetic serotonin depleting agents | A.H. ROBINS COMPANY, INCORPORATED (US) | 1989-02-08 | — | — | EP | disclosed |
| EP-0146067-A2 | Novel substrates for D-amino acid oxidase | MERRELL DOW PHARMACEUTICALS INC. (US) | 1985-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | HCN4, SLC46A1, FES | HTR2A 853/4885HTR2C 2980/4885HTR2B 1281/4885 |
| US-20130345475-A1 | PROCESS FOR THE RACEMIZATION OF OPTICALLY ACTIVE ARYLALKYLAMINES | HRH1, HNMT, HRH3 | HTR2A 256/4885HTR2C 188/4885HTR2B 129/4885 |
| US-20220102660-A1 | DEFECT SUPPRESSED METAL HALIDE PEROVSKITE LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING DIODE COMPRISING THE SAME | AXIN2, CRY2, PER2 | HTR2A 390/4885HTR2C 1454/4885HTR2B 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.